Crescendo Biologics Funding: $70M Raised, Series B (2023)

Crescendo Biologics is based in Cambridge, United Kingdom. It has raised $70M in total funding. Latest round: Series B.

Crescendo Biologics funding overview

Crescendo Biologics is based in Cambridge, United Kingdom. Crescendo Biologics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Crescendo Biologics runs through 2023; nothing later has been disclosed. Investors on record include Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda, Quan Capital and 1 others. 7 distinct backers are named across the disclosed rounds.

Crescendo Biologics at a glance

Total raised
$70M
Latest round
Series B
Latest round date
January 2023
Headquarters
Cambridge, United Kingdom
Notable investors
Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda, Quan Capital, Kreos Capital

Frequently asked about Crescendo Biologics funding

How much has Crescendo Biologics raised?
Crescendo Biologics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Crescendo Biologics?
Sofinnova Partners, Andera Partners, IP Group, BioNTech, Takeda, Quan Capital are named among the investors backing Crescendo Biologics.
What was the latest Crescendo Biologics funding round?
The most recent disclosed round is a Series B, announced in January 2023.
Where is Crescendo Biologics based?
Crescendo Biologics is based in Cambridge, United Kingdom.
When did Crescendo Biologics last raise?
The last disclosed Crescendo Biologics round closed in January 2023 at Series B.

Crescendo Biologics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Companies related to Crescendo Biologics (36)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades